BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 20172413)

  • 1. [Physiopathology of cardiovascular disease in HIV-infected patients].
    Alonso-Villaverde Lozano C
    Enferm Infecc Microbiol Clin; 2009 Sep; 27 Suppl 1():33-9. PubMed ID: 20172413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [HIV infection, antiretroviral therapy, and endothelium].
    Hürlimann D; Weber R; Enseleit F; Lüscher TF
    Herz; 2005 Sep; 30(6):472-80. PubMed ID: 16170677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immune factors in atherosclerosis].
    Pasqui AL; Bova G; Maffei S; Auteri A
    Ann Ital Med Int; 2005; 20(2):81-9. PubMed ID: 16052840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [HIV-related cardiovascular risk factors].
    Masiá M; Gutiérrez F
    Enferm Infecc Microbiol Clin; 2009 Sep; 27 Suppl 1():17-23. PubMed ID: 20172411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The basis and management of metabolic abnormalities associated with cardiovascular risk in human immunodeficiency virus infection and its treatment.
    Crook M
    Ann Clin Biochem; 2007 May; 44(Pt 3):219-31. PubMed ID: 17456292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiretroviral therapy with heart.
    Randell P; Moyle G
    Am J Ther; 2009; 16(6):579-84. PubMed ID: 19940610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [CD4 lymphocytes as targets and actors in the pathogenesis of HIV infection--therapeutic implications].
    Theze J
    Bull Acad Natl Med; 2008 Oct; 192(7):1453-66; discussion 1466-8. PubMed ID: 19445368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. From pathophysiology to targeted therapy for atherothrombosis: a role for the combination of statin and aspirin in secondary prevention.
    Chapman MJ
    Pharmacol Ther; 2007 Jan; 113(1):184-96. PubMed ID: 17070923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Commitment to apoptosis in CD4(+) T lymphocytes productively infected with human immunodeficiency virus type 1 is initiated by lysosomal membrane permeabilization, itself induced by the isolated expression of the viral protein Nef.
    Laforge M; Petit F; Estaquier J; Senik A
    J Virol; 2007 Oct; 81(20):11426-40. PubMed ID: 17670831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV type 1 infection, and not short-term HAART, induces endothelial dysfunction.
    Francisci D; Giannini S; Baldelli F; Leone M; Belfiori B; Guglielmini G; Malincarne L; Gresele P
    AIDS; 2009 Mar; 23(5):589-96. PubMed ID: 19177019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute cytomegalovirus infection induces a subendothelial inflammation (endothelialitis) in the allograft vascular wall. A possible linkage with enhanced allograft arteriosclerosis.
    Koskinen P; Lemström K; Bruggeman C; Lautenschlager I; Häyry P
    Am J Pathol; 1994 Jan; 144(1):41-50. PubMed ID: 8291611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV-1 Tat increases the adhesion of monocytes and T-cells to the endothelium in vitro and in vivo: implications for AIDS-associated vasculopathy.
    Matzen K; Dirkx AE; oude Egbrink MG; Speth C; Götte M; Ascherl G; Grimm T; Griffioen AW; Stürzl M
    Virus Res; 2004 Sep; 104(2):145-55. PubMed ID: 15246652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular biological assessment methods and understanding the course of the HIV infection.
    Katzenstein TL
    APMIS Suppl; 2003; (114):1-37. PubMed ID: 14626050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelial function in HIV-infected patients with low or mild cardiovascular risk.
    Blanco JJ; García IS; Cerezo JG; de Rivera JM; Anaya PM; Raya PG; García JG; López JR; Hernández FJ; Rodríguez JJ
    J Antimicrob Chemother; 2006 Jul; 58(1):133-9. PubMed ID: 16702174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [New information on the pathophysiology of atherosclerosis].
    Reiner Z; Tedeschi-Reiner E
    Lijec Vjesn; 2001; 123(1-2):26-31. PubMed ID: 11379194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fractalkine in vascular biology: from basic research to clinical disease.
    Umehara H; Bloom ET; Okazaki T; Nagano Y; Yoshie O; Imai T
    Arterioscler Thromb Vasc Biol; 2004 Jan; 24(1):34-40. PubMed ID: 12969992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Role of inflammation in atherogenesis].
    Rodríguez G; Mago N; Rosa F
    Invest Clin; 2009 Mar; 50(1):109-29. PubMed ID: 19418732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV and cardiovascular disease: contribution of HIV-infected macrophages to development of atherosclerosis.
    Bukrinsky M; Sviridov D
    PLoS Med; 2007 Jan; 4(1):e43. PubMed ID: 17411317
    [No Abstract]   [Full Text] [Related]  

  • 19. Cardiovascular risk factors and HIV disease.
    Fedele F; Bruno N; Mancone M
    AIDS Rev; 2011; 13(2):119-29. PubMed ID: 21587343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New aspects in the pathogenesis of diabetic atherothrombosis.
    Moreno PR; Fuster V
    J Am Coll Cardiol; 2004 Dec; 44(12):2293-300. PubMed ID: 15607389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.